Greenlight Capital BIO trades
David Einhorn
David Einhorn Bio-Rad Laboratories Inc stake
total: 364
Trades details
- Total transactions:
- 1
- New positions:
- 1
- Held for:
- 0 quarters
- Latest activity:
- 2026 Q3
According to 2026 Q3 report, David Einhorn holds 103,990 Bio-Rad Laboratories Inc (BIO) shares with a market value of roughly $39.28M accounting for 1.11% of the overall portfolio. Greenlight Capital first purchased BIO in 2026 Q3, initially acquiring 103,990 shares.
When did David Einhorn buy Bio-Rad Laboratories Inc (BIO)?
David Einhorn first invested in Bio-Rad Laboratories Inc (BIO) in 2026 Q3 at the reported quarter-end price of $377.71 per share.
David Einhorn's historical trades in Bio-Rad Laboratories Inc
1 result
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q3
|
1.11%
|
103,990
|
$377.71
|
$39,278,063
|
new
|
+1.11%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.